Related Experiment Video
Updated: Apr 16, 2026
06:49
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
Published on: March 14, 2014
12.2K
Trabectedin: Supportive care strategies and safety profile
Karin Jordan1, Franziska Jahn1, Berit Jordan2
1Department of Hematology/Oncology, University of Halle, Ernst-Grube-Str. 40, Halle 06120, Germany.
Critical Reviews in Oncology/Hematology
|March 22, 2015
Summary
Trabectedin is an antineoplastic drug for sarcoma and ovarian cancer. While generally well-tolerated, understanding its specific side effects and supportive care is crucial for patient management.
Area of Science:
- Oncology
- Pharmacology
Background:
- Trabectedin is an approved antineoplastic agent used for advanced soft tissue sarcomas and relapsed platinum-sensitive ovarian cancer.
- Its mechanism of action is not fully elucidated, but it exhibits a potentially favorable safety profile compared to traditional chemotherapy.
Purpose of the Study:
- To review the safety data of trabectedin.
- To provide an overview of supportive care strategies for managing trabectedin's adverse effects.
Main Methods:
- Review of existing safety data for trabectedin.
- Compilation of common toxicities and recommended supportive care measures.
Main Results:
- Common toxicities include neutropenia, nausea, vomiting, elevated liver transaminases, anemia, fatigue, thrombocytopenia, anorexia, and diarrhea.
- Many typical chemotherapy side effects are less common or milder with trabectedin.
- Supportive care strategies can effectively manage or mitigate most side effects.
Conclusions:
- Trabectedin presents a manageable therapeutic option, particularly in palliative care.
- Appropriate supportive care is essential for optimizing patient outcomes and tolerability.
- Awareness of specific adverse events and their management is key for safe trabectedin use.
Related Concept Videos
01:28Pulmonary Tuberculosis V
927
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
927
01:10Drugs that Destabilize Microtubules
4.4K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
01:15Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:29Venous Thrombosis III: Interprofessional Care
471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
743
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
743